Seeking Alpha

MissionIR's  Instablog

MissionIR
Send Message
We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices. It is our unwavering commitment to connect the investment community with companies that have great potential and a strong dedication to... More
My company:
MissionIR
My blog:
MissionIR Blog
  • Actinium Pharmaceuticals, Inc. (ATNM) Presenting At Biotech Showcase 2014 0 comments
    Jan 7, 2014 2:50 PM | about stocks: ATNM

    Actinium Pharmaceuticals, a New York-based biopharmaceutical company focusing on development of innovative immunotherapeutic solutions for advanced cancers treatment, today announced it will be presenting at the Biotech Showcase 2014 Conference. The conference will be taking place January 13-15, 2014 at the Wyndham Hotel in San Francisco California.

    Dr. Kaushik J. Dave, President and CEO of Actinium Pharmaceuticals, will be giving a corporate update on Monday, January 13, 2014, at 4:30 PM PST (Pacific Time) in the Mission II Room of the hotel. A webcast of the presentation will be available as well.

    For watching the presentation, onlookers are advised to use the following link: www.media-server.com/m/p/qbc4c7nh

    Actinium Pharmaceuticals is focusing on developing alpha particle radioimmunoconjugates for advanced cancers treatment. The company's targeted radiotherapy is based upon its proprietary platform for tapping into the power of alpha-emitting actinium-225 and bismuth-213 and specific beta-emitting radiopharmaceuticals in conjunction with monoclonal antibodies for cancer treatment. The company's primary radiopharmaceutical, Iomab(NYSE:TM)-B, will be utilized for patient preparation for bone marrow transplants. It is currently being tested in a Phase III clinical study in refractory and relapsed Acute Myeloid Leukemia (AML) patients over the age of 55. The company's secondary program, Actimab-A, is currently in clinical development.

    For more information, visit: actiniumpharmaceuticals.com

    MissionIR provides investor relations services to publicly traded companies in exchange for compensation. This article may be part of our efforts to widen a client's exposure. To read our full disclaimer, visit http://disclaimer.missionir.com

    Stocks: ATNM
Back To MissionIR's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.